Epstein Barr Virus IgG
Clinical Background:
Screening test for PAST EBV infection. Used in certain patients prior to transplant to assess risk for post transplant lymphoproliferative disease. Please note IgG assay can be affected by passivel...
Screening test for PAST EBV infection. Used in certain patients prior to transplant to assess risk for post transplant lymphoproliferative disease. Please note IgG assay can be affected by passively acquired antibody where blood products have been administered, or by maternally acquired antibodies in the first months of life.
Test Details
-
Discipline:
Microbiology
Microbiology
-
Specimen Container Adult:
Clotted blood - Gold SST
Clotted blood - Gold SST
-
Specimen Container Paediatric:
Clotted blood
Clotted blood
-
Minimum Volume Adult:
5 ml
5 ml
-
Minimum Volume Paediatric:
1 ml
1 ml
-
Special Requirement:
Send to laboratory as quickly as possible. If delays likely, refrigerate at 2-8 deg C
Send to laboratory as quickly as possible. If delays likely, refrigerate at 2-8 deg C
-
Sample Stability:
Stable for up to 24 hours
Stable for up to 24 hours
-
Transport Requirements:
Standard
Standard
-
Add On Test:
Possible up to 5 days
Possible up to 5 days
-
Quality Assurance:
UK National External Quality Assurance Scheme (UKNEQAS)
UK National External Quality Assurance Scheme (UKNEQAS)
-
Interpretation:
Screening test for PAST Epstein Barr Virus infection.
Screening test for PAST Epstein Barr Virus infection.
-
Reference Ranges:
None available
None available
-
Factors Affecting Result:
If delays likely, refrigerate at 2-8 deg C
If delays likely, refrigerate at 2-8 deg C
-
Referenced Documents:
Standards of Microbiology Investigations (SMI V26)
Standards of Microbiology Investigations (SMI V26)